SOURCE: Takeda

DESCRIPTION:

Takeda’s flagship Access to Medicines initiative, the Blueprint for Innovative Healthcare Access program, works with a consortium of public and private partners sharing resources and responsibility, each bringing specific strengths and expertise to address rising Non-Communicable Diseases (NCDs) challenges in underserved communities. Meet the people who are living and breathing the Blueprint in the second episode focusing on the importance of screening of NCDs of a 5-part series of our pilot program in Meru County, Kenya.

Tweet me: Meet the people who are living and breathing @Takeda's Blueprint in the second episode focusing on the importance of screening of NCDs of a 5-part series of our pilot program in Meru County, Kenya. https://bit.ly/3w5qELy

KEYWORDS: takeda, Blueprint for Access to Innovative Healthcare, NYSE:TAK